Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene

Blood

Volumn 87, Issue 4, 1996, Pages 1571-1578

  Joos, Stefan ^b   Otaño Joos, Marta I ^b   Ziegler, Susanne ^b   Brüderlein, Silke ^b   Du Manoir, Stanislas ^b   Bentz, Martin ^b   Möller, Peter ^b   Lichter, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CHROMOSOME 12Q; CHROMOSOME 9P; CHROMOSOME XQ; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MALE; MEDIASTINUM MASS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0030041048     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1571.bloodjournal8741571     Document Type: Article

References (45)

1. Addis BJ, Isaacson PG: Large cell lymphoma of the mediastinum: A B-cell tumour of probable thymic origin. Histopathology 10:379, 1986
2. Menestrina F, Chilosi M, Bonetti F, Lestani M, Scarpa A, Novelli P, Doglioni C, Todeschini G, Ambrosetti A, Fiore-Donati L: Mediastinal large-cell lymphoma of B-type, with sclerosis: Histopathological and immunohistochemical study of eight cases. Histopathology 10:589, 1986
3. Möller P, Lämmler B, Eberlein-Gonska M, Feichter GE, Hofman WJ, Schmitteckert H, Otto HF: Primary mediastinal clear cell lymphoma of B-cell type. Virchows Arch A Pathol Anat Histopathol 409:79, 1986
4. Perrone T, Frizzera G, Rosai J: Mediastinal diffuse large-cell lymphoma with sclerosis. Am J Surg Pathol 10:176, 1986
5. Lamarre L, Jacobson JO, Aisenberg AC, Harris NL: Primary large cell lymphoma of the mediastinun. Am J Surg Pathol 13:730, 1989
6. Carr TF, Lockwood L, Stevens RF, Morris-Jones PH, Lewis I, DaCosta PE, Kelsey AM: Childhood B cell lymphomas arising in the mediastinum. J Clin Pathol 46:513, 1993
7. Kirn D, Mauch P, Pinkus G, Shipp MA, Kaplan WD, Tung N, Wheeler C, Beard CJ, Canellos GP, Shulman LN: Large-cell and immunoblastic lymphoma of the mediastinum: Prognostic features and treatment outcome in 57 patients. J Clin Oncol 11:1336, 1993
8. Davis RE, Dorfman RF, Warnke RA: Primary large-cell lymphoma of the thymus. Hum Pathol 21:1262, 1990
9. Möller P, Hofmann WJ, Mielke B, Otto HF: Das primär mediastinale, hellzellige B-Zell-Lymphom ist ein epithelassoziiertes Thymuslymphom. Pathologe 10:234, 1989
10. Scarpa A, Bonetti F, Menestrina F, Menegazzi M, Chilosi M, Lestani M, Bovolenta C, Zamboni G, Fiore-Donati L: Mediastinal large-cell lymphoma with sclerosis. Virchows Arch A Pathol Anat Histopathol 412:17, 1987
11. Brandter LB, Smith CIE, Hammarström L, Lindermalm C, Christensson B: Clonal immunoglobulin gene rearrangements in primary mediastinal clear cell lymphoma. Leukemia 3:122, 1989
12. Knauf WU, Ho AD, Heger G, Doerken B, Möller P: Mediastinal clear cell lymphoma-a distinct entity of B-Cell derived lymphoma as shown by immunotyping and analysis of gene rearrangements. Leuk Lymphoma 6:49, 1991
13. Möller P, Moldenhauer G, Momburg F, Lämmler B, Eberlein-Gonska M, Kiesel S, Dörken B: Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood 69:1087, 1987
14. Moller P, Herrmann B, Moldenhauer G, Momburg F: Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy. Int J Cancer 40:32, 1987
15. Momburg F, Herrmann B, Moldenhauer G, Möller P: B-cell lymphomas of high grade malignancy frequently lack HLA-DR, -DP, and -DQ antigens and associated invariant chain. Int J Cancer 40:598, 1987
16. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink H.-K., Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
17. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818, 1992
18. Du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Döhner H, Kovacs G, Robert Nicoud M, Lichter P, Cremer T: Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590, 1993
19. Joos S, Scherthan H, Speicher MR, Schlegel J, Cremer T, Lichter P: Detection of amplified genomic sequences by reverse chromosome painting using genomic tumor DNA as probe. Hum Genet 90:584, 1993
20. Lichter P, Bentz M, du Manoir S, Joos S: Comparative genomic hybridization, in Verma RS, Babu A (eds): Human Chromosomes. New York, NY, McGraw Hill, 1995, p 191
21. Bentz M, Huck K, du Manoir S, Joos S, Werner C, Fischer K, Döhner H, Lichter P: Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 85:3610, 1995
22. Joos S, Bergerheim USR, Pan Y, Matsuyama H, Bentz M, du Manoir S, Lichter P: Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosom Cancer (in press)
23. Du Manoir S, Schröck E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T: Quantitative analysis of comparative genomic hybridization. Cytometry 19:27, 1995
24. Bentz M, Döhner H, Huck K, Schütz B, Ganser A, Joos S, du Manoir S, Lichter P: Comparative genomic hybridization in the investigation of myeloid leukemias. Genes Chromosom Cancer 12:193, 1995
25. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10:231, 1994
26. Dreyling MH, Bohlander SK, Adeanju MO, Olopade OL: Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res 55:984, 1995
27. Stilgenbauer S, Döhner H, Bulgay-Mörschel M, Weitz S, Bentz M, Lichter P: High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 81:2118, 1993
28. Hopman AHN, Poddighe P, Moesker O, Ramaekers FCS: Interphase cytogenetics: An approach to the detection of genetic abberations in tumours, in Herrington CS, McGee JOD (eds): Diagnostic Molecular Pathology. A Practical Approach, vol 1. New York, NY, IRL, 1992, p 142
29. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1982
30. Schmitz ML, dos Santos Silva M, Altmann H, Czisch M, Holak TA, Baeuerle PA: Structural and functional analysis of the NF-kB p65 C terminus. J Biol Chem 269:25613, 1994
31. Brownell E, Mittereder N, Rice NR: A human rel protooncogene cDNA containing an Alu fragment as a potential coding exon. Oncogene 4:935, 1989
32. Lichter P, Umeda PK, Levin JE, Vosberg H-P: Partial characterization of the human β-myosin heavy chain gene which is expressed in heart and skeletal muscle. Eur J Biochem 160:419, 1986
33. Brownell E, Fell HP, Tucker PW, Geurts van Kessel AHM, Hagemeijer A, Rice NR: Regional localization of the human c-rel locus using translocation chromosome analysis. Oncogene 2:527, 1988
34. Mathew S, Murty VVVS, Dalla-Favera R, Chaganti RSK: Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kBp50, NF-kBp65 and lyt-10 by fluorescence in situ hybridization. Oncogene 8:191, 1993
35. Bose HR Jr: The Rel family: Models for transcriptional regulation and oncogenic transformation. Biochim Biophys Acta 1114:1, 1992
36. Offit K, Richardson ME, Quanguang C, Hampton A, Koduru PRK, Jhanwar SC, Filippa D, Lieberman PH, Clarkson B, Chaganti RSK: Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma. Cancer Genet Cytogenet 37:85, 1989
37. Offit K, Jhanwar SC, Ladanyi M, Filippa D, Chaganti RSK: Cytogenetic analysis of 434 consecutively ascertained specimens on non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosom Cancer 3:189, 1991
38. Huret JL, Brizard A, Babin P, Schoenwald M, Briault S, Guilhot F, Tanzer J: Translocation (8;9)(q12;p21). A new nonrandom rearrangement in lymphoid malignancies. Cancer Genet Cytogenet 45:125, 1990
39. Paietta E, Van-Ness B, Le Beau MM, Bennett J, Cassileth P, Wiernik PH: Translocation (2;9)(p12;p23) in a case of acute leukemia with t(4;11)(q21;q23). Lack of rearrangement of the kappa and interferon gene loci. Cancer Genet Cytogenet 60:82, 1992
40. Offit K, Parsa NZ, Jhanwar SC, Filippa D, Wachtel M, Chaganti RSK: Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma. Genes Chromosom Cancer 7:1, 1993
41. McAlpine PJ, Shows T, Boucheix C, Pericak-Vance MA, Anderson WA: The 1992 catalog of mapped genes and report of the nomenclature committee. Genome Priority Rep 1:11, 1993
42. Oscier DG: Cytogenetic and molecular abnormalities in chronic lymphocytic leukemia. Blood Rev 8:88, 1994
43. Juliusson G, Gahrton G: Chromosome abnormalities in B-cell chronic lymphocytic leukemia, in Cheson BD (ed): Chronic Lymphocytic Leukemia. New York, NY, Marcel Dekker, 1993, p 83
44. Lu D, Thompson JD, Gorski GK, Rice NR, Mayer MG, Yunis JJ: Alterations at the rel locus in human lymphoma. Oncogene 6:1235, 1991
45. Hammond DW, Goepel JR, Aitken M, Hancock BW, Potter AM, Goyns MH: Cytogenetic analysis of a United Kingdom series of non Hodgkin's lymphomas. Cancer Genet Cytogenet 61:31, 1992